Device outcomes in pediatric sacral neuromodulation: A single center series of 187 patients.

Introduction: Pediatric sacral neuromodulation (SNM) device duration before revision or removal is not well known. Furthermore, secondary surgeries serve as surrogates for key outcomes including complications and symptom improvement.

Objective: We sought to study the rate and causes of secondary surgeries in pediatric SNM patients.

Sacral neuromodulation for the dysfunctional elimination syndrome: a 10-year single-center experience with 105 consecutive children.

Objective: To evaluate our initial experience using sacral neuromodulation via implanted pulse generator as a treatment for children with dysfunctional elimination syndrome and symptoms refractory to maximum medical therapy.

Materials And Methods: There were 105 consecutive patients who underwent a 2-stage procedure with a trial period (n = 89) or a single procedure (n = 16) for device implantation. They were followed up prospectively for a median of 2.

Vesicoureteral reflux in children with urachal anomalies.

Objective: We report the largest known series of vesicoureteral reflux (VUR) in children with urachal anomalies (UA).

Methods: Two institutions' records were reviewed for children with UA (1951‒2007).

Results: Of 30 girls and 36 boys with UA (34 urachal cysts, 14 patent urachus, 10 urachal diverticula, 7 urachal sinuses, and 1 unknown), 57 (86%) underwent surgical resection or drainage.

Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children.

Purpose: Recent advances in neuromodulation have demonstrated promise in treating children with the dysfunctional elimination syndrome refractory to medical management. Sacral nerve stimulation with the InterStim implantable device has been used in adults for management of chronic urinary complaints. However, there are few data regarding the usefulness of sacral nerve stimulation in children.

Familial multilocular cystic nephroma: a variant of a unique renal neoplasm.

Multilocular cystic nephroma (MCN) is a benign renal lesion believed to be unilateral and nonfamilial. We present 2 cases of MCN in 2 brothers. The older brother had a 10-cm MCN and required radical nephrectomy, and the younger brother had bilateral lesions (6 cm and 3 cm) for which nephron-sparing surgery was possible.

Preliminary results of sacral neuromodulation in 23 children.

Purpose: Sacral nerve stimulation with InterStim is approved in the United States for use in adults. Limited data on the effectiveness of sacral nerve stimulation in children are available. We report our experience with patients who underwent InterStim placement for the treatment of severe dysfunctional elimination syndrome, which is defined as a constellation of functional urinary and gastrointestinal symptoms in patients without anatomical anomalies or obvious neurological disease, in whom intensive medical and behavioral therapies have failed to improve symptoms.

Contemporary and emerging drug treatments for urinary incontinence in children.

Pediatric incontinence is a bothersome symptom for children and their parents. It can have a profound influence on a child's social and psychologic development and well-being. It is important to understand the different disorders that result in incontinence and also to understand the neural influences and development on urinary control.

Neuromodulation in pediatrics.

Several neuromodulatory options are available for selected children who have voiding dysfunction resistant to conventional therapy. Integral to all types of treatment is an educated team that reinforces progress rather than cure and encourages long-term behavioral changes.